Previous 10 | Next 10 |
Announces $35 Million Above Market Financing Bolsters Company’s Position with Ongoing Strategic Discussions BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) , a leading agricultural biotechnology company dedicated to imp...
22nd Century Group ( NASDAQ: XXII ) has announced a $35M share and warrant offering priced above market under Nasdaq rules. The offering will consist of 17,073,175 shares of common stock issued at $2.05/share. The company also agreed to offer unregistered warrants to purch...
BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it has entere...
Alan Sumler comes from the world of academia and brings that perspective to cannabis investing. Long positions and how he approaches his stock analysis. Psychedelic and cannabis overlap. Medical and historical lens. A rare opinion - Positive on Canada! Playing options, bal...
With the Food and Drug Administration (FDA) signaling in June that it's developing a proposal for a new set of standards that would put a hard cap on the level of nicotine allowed in cigarettes to reduce their addictiveness, shares of 22nd Century Group (NASDAQ: XXII) are burgeoning...
A new 2022/23 study continues the trading studies from 2017 testing abnormal Russell Index reconstitution returns from scholarly literature. Since 2017 the best return results from a price momentum test generated +57.90% in the first six months and average gains reached +29.04% in the...
The Food & Drug Administration (FDA) is busy these days. Even as a recent decision could effectively hand the electronic cigarette market to British American Tobacco (NYSE: BTI) by banning chief rival Juul Labs from store shelves, it has also taken another momentous step that co...
Cigarettes just might be getting a whole lot less stimulating, per a new rule limiting the amount of nicotine in cigarettes being proposed by the regulators at the Food and Drug Administration (FDA). While the proposed rule probably won't be finalized enough for the public to comment on it ...
The following slide deck was published by 22nd Century Group, Inc. in conjunction with this event. For further details see: 22nd Century Group (XXII) Investor Presentation - Slideshow
22nd Century Group 's (NASDAQ: XXII) stock is up more than 22% as of noon ET today as a result of a new rule proposed by the Food and Drug Administration (FDA) that would limit the amount of nicotine contained in cigarettes. The move would reduce their addictiveness and therefore th...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...